subject_id=CHC018;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC018;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC018;gender=female;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC018;gender=female;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
subject_id=CHC255;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC255;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC255;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC255;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC304;gender=male;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC304;gender=male;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC304;gender=male;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC304;gender=male;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC309;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC309;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC309;gender=female;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC309;gender=female;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC314;gender=male;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC314;gender=male;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC314;gender=male;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC314;gender=male;phenotype=hepatocellular carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
subject_id=CHC334;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC334;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC334;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC334;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
ENA-SUBMISSION-TOOL=SRA-Webin;
subject_id=CHC442;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC442;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC442;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC442;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC906;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC906;gender=female;phenotype=non-tumor liver;disease_site=liver;sample type=normal tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC906;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
subject_id=CHC906;gender=female;phenotype=fibrolamellar carcinoma;disease_site=liver;sample type=diseased tissue;ENA-CHECKLIST=ERC000026;
